Xiaolan Wu

ORCID: 0000-0003-1386-3414 · 2 papers in corpus
review 2025
Frontiers in immunology ·doi:10.3389/fimmu.2025.1578723

Ovarian cancer(OC) is the second most common gynecological malignancy worldwide. While traditional treatments such as cytoreductive surgery, chemotherapy, and targeted drugs have made progress, patients with advanced disease still face high…

other 2022
Women & health ·doi:10.1080/03630242.2022.2144986

Endometriosis (EMS) is a challenging gynecological disorder prevalent in reproductive-aged women, and Th1/Th2 cytokines are implicated in EMS progression. This study probed the serum levels and clinical values of Th1/Th2 cytokines in EMS pa…